Novartis AG said profit will rise this year as new medicines help offset competition from copycats of its best-selling drug, ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet selected for price negotiation, according to a report released Thursday.

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic top the list of 15 drugs selected for the second round of federal price negotiations, which are scheduled to begin this year ...

Medicare announced plans to negotiate lower prices for 15 costly drugs, including Ozempic, Wegovy, and Trelegy Ellipta, starting in 2027. These medications, used for conditions like diabetes, weight ...

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a study reporting one in eight Americans has taken or is currently using the drugs to ...

Last year, 12% of U.S. adults reported taking a GLP-1 drug, according to one poll; 6% said they were currently on one. In 2024, Ozempic, Rybelsus and Wegovy (semaglutide) were the most popular ...